Revenues from Contracts with Customers

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the Annual Report on Form 10-K.

Disaggregation of Revenue

The disaggregation of revenue is based on reporting segment, product category and geographical region. Beginning in the first quarter of 2020, we revised our product categories to more clearly reflect how we sell our products to our customers. We presented historical information under the new revised product categories in a Current Report on Form 8-K, filed with the SEC on April 3, 2020.

We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer

localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and nine-month periods ended September 30, 2020 and 2019 (in thousands):

	Three Months Ended						Three Months Ended
	September 30, 2020						September 30, 2019
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	55,014	$	31,764	$	86,778	$	55,587	$	28,678	$	84,265
Cardiac Intervention		28,661		40,428		69,089		29,657		45,202		74,859
Custom Procedural Solutions		32,048		24,381		56,429		24,906		21,352		46,258
OEM		20,293		3,824		24,117		25,521		3,523		29,044
Total		136,016		100,397		236,413		135,671		98,755		234,426
Endoscopy
Endoscopy devices		7,093		469		7,562		8,340		283		8,623
Total	$	143,109	$	100,866	$	243,975	$	144,011	$	99,038	$	243,049

	Nine Months Ended						Nine Months Ended
	September 30, 2020						September 30, 2019
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	153,431	$	93,057	$	246,488	$	167,158	$	90,586	$	257,744
Cardiac Intervention		79,954		127,731		207,685		85,817		141,225		227,042
Custom Procedural Solutions		80,845		68,524		149,369		73,871		65,464		139,335
OEM		67,566		13,026		80,592		75,425		12,024		87,449
Total		381,796		302,338		684,134		402,271		309,299		711,570
Endoscopy
Endoscopy devices		20,509		1,228		21,737		24,459		901		25,360
Total	$	402,305	$	303,566	$	705,871	$	426,730	$	310,200	$	736,930